NCT03227653 - Neuropsychiatric Side Effects of Efavirenz in Children Living With HIV | Biotech Hunter

Enrollment

144

Participants

Timeline

Start Date

June 19, 2017

Primary Completion Date

December 31, 2017

Study Completion Date

December 31, 2017

Conditions

EfavirenzChild BehaviorCognitive SymptomMedication AdherenceDrug-Related Side Effects and Adverse Reactions

Interventions

DRUG

Efavirenz

Weight-based dosing according to the National Guidelines for the Management of HIV and AIDS

DRUG

Nevirapine

Weight-based dosing according to the National Guidelines for the Management of HIV and AIDS

DRUG

Lopinavir-Ritonavir Drug Combination

Weight-based dosing according to the National Guidelines for the Management of HIV and AIDS

Trial Locations (6)

Kilimanjaro Christian Medical Centre, Moshi

Mawenzi Regional Hospital, Moshi

Kibosho Hospital, Kibosho

Kiboroloni Dispensary, Moshi

Majengo Health Centre, Moshi

Pasua Health Centre, Moshi